Crossmark

Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study

Crossref DOI link: https://doi.org/10.1016/S2213-8587(16)00112-1

Published Print: 2016-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Wallis, Christopher J D

Lo, Kirk

Lee, Yuna

Krakowsky, Yonah

Garbens, Alaina

Satkunasivam, Raj

Herschorn, Sender

Kodama, Ronald T

Cheung, Patrick

Narod, Steven A

Nam, Robert K
Funding

Funding for this research was provided by:

Government of Ontario

Physicians' Services Incorporated Foundation

Canadian Institutes of Health Research
License Information

Text and Data Mining valid from 2016-06-01
More Information

This article is maintained by: Elsevier

Article Title: Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study

Journal Title: The Lancet Diabetes & Endocrinology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S2213-8587(16)00112-1

CrossRef DOI link to the associated document: https://doi.org/10.1016/S2213-8587(16)30008-0

Content Type: article

Copyright: © 2016 Elsevier Ltd. All rights reserved.